Go to content
UR Home

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

Eigentler, Thomas K. ; Figl, Adina ; Krex, Dietmar ; Mohr, Peter ; Mauch, Cornelia ; Rass, Knut ; Bostroem, Azize ; Heese, Oliver ; Koelbl, Oliver ; Garbe, Claus ; Schadendorf, Dirk



Abstract

The overall survival of patients with BM-MM primarily depends on the number of metastases and pretreatment level of LDH. In the case of a single brain metastasis, stereotactic radiotherapy or neurosurgical metastasectomy is by far the most important factor for improving survival.


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -5707

Contact persons